Here are four highlights:
1. The Cyclo G6 laser system is dedicated specifically to treat patients diagnosed with a range of glaucoma disease states. The system features the company’s MicroPulse tissue-sparing technology and a family of single use probes that connect to an intuitive, user-friendly laser console.
2. Keith Barton, MD, consultant ophthalmologist of glaucoma service of Moorfields Eye Hospital in London, England, said some studies of the Cyclo G6 have shown a 30 percent to 40 percent reduction in intraocular pressure, and adds the ability to reduce IOP without incisions nor using implants in a quick procedure is a highlight.
3. The Cyclo G6 laser system will be sold with two disposable probes, the MicroPulse 3 probe for use with a broad range of glaucoma patients and the G-Probe for later stage patients. The company also plans to introduce a series of additional new probes in the coming year that allow for additional applications in glaucoma treatment.
4. IRIDEX is a global provider of innovative laser systems, delivery devices and consumables in ophthalmology.
More articles on healthcare:
Los Alamitos Surgery Center to provide prostate cancer treatment: 4 things to know
SCA added to S&P SmallCap 600, HCA to buy Texas hospital for $96M — 4 key notes on ASC companies
Hip, knee replacement rates vary by up to 232% among Colorado insurers: 5 findings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.